KR20210069513A - The toothpaste composition having oral bactericidal function - Google Patents

The toothpaste composition having oral bactericidal function Download PDF

Info

Publication number
KR20210069513A
KR20210069513A KR1020190159425A KR20190159425A KR20210069513A KR 20210069513 A KR20210069513 A KR 20210069513A KR 1020190159425 A KR1020190159425 A KR 1020190159425A KR 20190159425 A KR20190159425 A KR 20190159425A KR 20210069513 A KR20210069513 A KR 20210069513A
Authority
KR
South Korea
Prior art keywords
weight
extract
toothpaste composition
pegmatite
silicon dioxide
Prior art date
Application number
KR1020190159425A
Other languages
Korean (ko)
Inventor
김은실
정상명
Original Assignee
김은실
정상명
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김은실, 정상명 filed Critical 김은실
Priority to KR1020190159425A priority Critical patent/KR20210069513A/en
Publication of KR20210069513A publication Critical patent/KR20210069513A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/965Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a toothpaste composition having an oral bacteria-inhibiting function. The composition comprises: 1.50-2.50 wt% of pegmatite; 1.50-8.50 wt% of silicon dioxide; 10.42-17.60 wt% of dental type silica; 0.04-0.06 wt% of allantoin chlorohydroxyaluminum; 0.02-0.06 wt% of aminocaproic acid; 26.00-70.00 wt% of a D-sorbitol solution; 4.00-6.00 wt% of concentrated glycerin; 0.60-1.40 wt% of polyethylene glycol 1500; 0.60-1.40 wt% of sodium carboxymethyl cellulose; 0.06-0.14 wt% of a Matricaria extract; 0.06-0.14 wt% of a sage extract; 0.06-0.14 wt% of an eucalyptus globulus extract; 0.06-0.14 wt% of aloe extract; 0.12-0.28 wt% of a grapefruit seed extract; 0.06-0.14 wt% of xylitol; 0.04-0.06 wt% of enzyme-treated stevia; 0.30-0.60 wt% of L-mental; 0.10-0.30 wt% of mint flavor; 0.20-0.60 wt% of mica; 0.006-0.014 wt% of silver foil; 1.00-3.00 wt% of sodium cocoyl glutamate; and 8.58-31.60 wt% of purified water with respect to the total weight of the toothpaste composition. A particle size of the silicon dioxide is 6-22 μm, and the particle sizes of the dental type silica and pegmatite are 1-20 μm, respectively. Therefore, the composition of the present invention has excellent effects of removing plaque and preventing the deposition of tartar, and has excellent deodorization and antibacterial effects, and thus is useful for maintaining teeth and gums healthy.

Description

구강내 세균억제 기능을 갖는 치약 조성물{The toothpaste composition having oral bactericidal function}The toothpaste composition having oral bactericidal function

본 발명은 치약 조성물에 관한 것으로서, 보다 상세하게는 주성분으로서 이산화규소, 덴탈타입실리카, D-소르비톨액, 농글리세린, 코코일글루타민산나트륨 및 페그마타이트 등이 포함되어 구취 제거, 항균작용 및 치태 억제 효과가 우수한 구강내 세균억제 기능을 갖는 치약 조성물에 관한 것이다.The present invention relates to a toothpaste composition, and more particularly, silicon dioxide, dental type silica, D-sorbitol solution, concentrated glycerin, sodium cocoyl glutamate and pegmatite, etc. It relates to a toothpaste composition having an excellent oral bacteriostatic function.

본 발명의 기술이 속하는 치약은 치아를 청결하게 하고 연마할 목적으로 칫솔에 묻혀 사용하는 약물성 복합물질이다. 형태는 분말, 크림 또는 액상 등으로 이루어지고, 소독작용, 치석용해작용, 냄새감퇴작용 및 충치나 치조농루 등의 예방 또는 치료에 도움을 줄 수 있도록 만들어진다.The toothpaste to which the technology of the present invention belongs is a drug compound used by being buried in a toothbrush for the purpose of cleaning and polishing teeth. The form consists of powder, cream or liquid, etc., and is made to help prevent or treat sterilization, tartar dissolution, odor reduction, and tooth decay or pyorrhea.

종래에 주로 사용되는 기제에는 탄산칼슘, 인산칼슘, 황산칼슘, 탄산마그네슘, 염화마그네슘 등이 사용되고, 주로 치아의 기계적 청소에 효과적으로 작용하도록 사용되며, 입자의 크기와 경도 및 모양이 적당하지 않으면 치아의 표면을 손상시킬 우려가 있으므로, 입자의 크기는 대략 1~20㎛로서 균일하게 만들고, 결정은 치아가 상하지 않도록 예민하지 않게 만들며, 경도는 모스 굳기 3도 정도로 만든다.Calcium carbonate, calcium phosphate, calcium sulfate, magnesium carbonate, magnesium chloride, etc. are used as bases mainly used in the prior art, and are mainly used to effectively act for mechanical cleaning of teeth. Since there is a risk of damaging the surface, the size of the particles is made uniform as about 1-20㎛, the crystals are made not sensitive so as not to damage the teeth, and the hardness is made about 3 degrees Mohs hardness.

상기와 같은 기제 외에 청정제, 향료, 색소, 살균소독제, 치석용해제, 중화제 등이 조금씩 혼입되어 있으며, 크림 타입에는 이외에도 접합제, 안정제 등이 첨가되고 있다.In addition to the above-mentioned bases, cleaning agents, fragrances, pigments, disinfectants, tartar dissolving agents, neutralizing agents, etc. are mixed little by little, and in addition to the cream type, binders, stabilizers, etc. are added.

대한민국 등록특허 제314789호는 충치 예방 및 구강내 염증에 억제효과를 나타내는 치약 조성물에 있어서, 스핀고리피드를 활성성분으로 함유하는 충치 예방 및 구강내 염증 치료용 치약 조성물이 게재되어 있고, 대한민국 등록특허 제482648호는 옥 파우더 0.01~10중량% 및 두송나무 열매 추출물 0.001~10중량%가 함유된 치약조성물이 게재되어 있으며, 대한민국 공개특허 제2001-20067호에는 습윤제, 연마제, 점도조절제, 기포제 등으로 구성되는 치약 조성물에 있어서, 향치료법에 사용되는 천연의 에센셜 오일류를 그 종류에 따라 0.3~2.5중량% 만큼 α타입, β타입, γ타입의 싸이클로덱스트린의 혼합체 3.0~25.0중량%에 포접시켜 아로마테라피용 에센셜 오일을 함유하는 치약 조성물 및 그의 제조방법이 게재되어 있다.Republic of Korea Patent No. 314789 discloses a toothpaste composition for preventing tooth decay and treating inflammation in the oral cavity, which contains spingolipid as an active ingredient, in a toothpaste composition that has an inhibitory effect on caries prevention and oral inflammation. No. 482648 discloses a toothpaste composition containing 0.01 to 10% by weight of jade powder and 0.001 to 10% by weight of cypress fruit extract, and Korean Patent Laid-Open No. 2001-20067 discloses a humectant, abrasive, viscosity modifier, foaming agent, etc. In the toothpaste composition, the natural essential oils used for aromatherapy are included in 3.0 to 25.0 wt% of a mixture of α-type, β-type, and γ-type cyclodextrin by 0.3 to 2.5% by weight depending on the type of aromatherapy. Disclosed are a toothpaste composition containing dragon essential oil and a method for preparing the same.

그러나, 종래기술에서는 페그마타이트(Pegmatite)를 함유하는 치약 조성물에 대해서는 게재된 바 없다.However, in the prior art, there is no publication for a toothpaste composition containing pegmatite.

따라서, 본 발명은 구취 제거, 항균작용 및 치태 억제 효과를 우수하게 발현시키고자 주성분으로서 페그마타이트를 포함하여 이산화규소, 덴탈타입실리카, D-소르비톨액, 농글리세린 및 코코일글루타민산나트륨이 포함된 구강내 세균억제 기능을 갖는 치약 조성물을 제공하고자 한다.Therefore, the present invention provides an oral cavity containing silicon dioxide, dental type silica, D-sorbitol solution, concentrated glycerin, and sodium cocoyl glutamate, including pegmatite as main components, in order to excellently express bad breath removal, antibacterial action and plaque suppression effect. An object of the present invention is to provide a toothpaste composition having a bacteriostatic function.

본 발명에 따른 구강내 세균억제 기능을 갖는 치약 조성물의 구체적인 성분은, 치약 조성물의 총중량에 대하여 페그마타이트 1.50~2.50중량%, 이산화규소 1.50~8.50중량%, 덴탈타입실리카 10.42~17.60중량%, 알란토인클로로히드록시알루미늄 0.04~0.06중량%, 아미노카프로산 0.02~0.06중량%, D-소르비톨액 26.00~70.00중량%, 농글리세린 4.00~6.00중량%, 폴리에틸렌글리콜1500 0.60~1.40중량%, 카르복시메틸셀룰로오스나트륨 0.60~1.40중량%, 마트리카리아엑스 0.06~0.14중량%, 세이지엑스 0.06~0.14중량%, 유칼립투스추출물 0.06~0.14중량%, 알로에엑스 0.06~0.14중량%, 자몽종자추출물 0.12~0.28중량%, 자일리톨 0.06~0.14중량%, 효소처리스테비아 0.04~0.06중량%, L-멘톨 0.30~0.60중량%, 민트향 0.10~0.30중량%, 마이카 0.20~0.60중량%, 은박 0.006~0.014중량%, 코코일글루타민산나트륨 1.00~3.00중량% 및 정제수 8.58~31.60중량%가 포함되고, 상기 이산화규소의 입자 크기는 6~22μm이며, 상기 덴탈타입실리카 및 페그마타이트의 입자 크기는 각각 1~20μm이다.Specific components of the toothpaste composition having an oral bacterial inhibiting function according to the present invention are 1.50 to 2.50% by weight of pegmatite, 1.50 to 8.50% by weight of silicon dioxide, 10.42 to 17.60% by weight of dental type silica, allantoin chloro, based on the total weight of the toothpaste composition. hydroxyaluminum 0.04 to 0.06 wt%, aminocaproic acid 0.02 to 0.06 wt%, D-sorbitol solution 26.00 to 70.00 wt%, concentrated glycerin 4.00 to 6.00 wt%, polyethylene glycol 1500 0.60 to 1.40 wt%, sodium carboxymethylcellulose 0.60 ~1.40% by weight, Matricaria extract 0.06~0.14% by weight, sage extract 0.06~0.14% by weight, eucalyptus extract 0.06~0.14% by weight, aloe extract 0.06~0.14% by weight, grapefruit seed extract 0.12~0.28% by weight, xylitol 0.06 ~0.14% by weight, enzyme-treated stevia 0.04 to 0.06% by weight, L-menthol 0.30 to 0.60% by weight, mint flavor 0.10 to 0.30% by weight, mica 0.20 to 0.60% by weight, silver foil 0.006 to 0.014% by weight, sodium cocoyl glutamate 1.00 ~3.00% by weight and 8.58 ~ 31.60% by weight of purified water is included, the particle size of the silicon dioxide is 6 ~ 22μm, the particle size of the dental type silica and pegmatite is 1 ~ 20μm, respectively.

본 발명에 따른 구강내 세균억제 기능을 갖는 치약 조성물을 사용하게 되면, 치태 제거 및 치석의 침착 방지 효과가 우수하고, 구취 제거 및 항균작용이 탁월하여 치아와 잇몸을 건강하게 유지하는데 유용한 효과가 발생된다.When the toothpaste composition having the oral bacterial inhibiting function according to the present invention is used, the effect of removing plaque and preventing the deposition of tartar is excellent, and the effect of removing bad breath and antibacterial action is excellent, so that it is useful for keeping teeth and gums healthy. do.

본 발명에 따른 구강내 세균억제 기능을 갖는 치약 조성물에는 페그마타이트, 이산화규소, 덴탈타입실리카, 알란토인클로로히드록시알루미늄, 아미노카프로산, D-소르비톨액, 농글리세린, 폴리에틸렌글리콜1500, 카르복시메틸셀룰로오스나트륨, 마트리카리아엑스, 세이지엑스, 유칼립투스추출물, 알로에엑스, 자몽종자추출물, 자일리톨, 효소처리스테비아, L-멘톨, 민트향, 마이카, 은박, 코코일글루타민산나트륨 및 정제수가 일정한 비율로 포함된다.The toothpaste composition having an oral bacterial inhibiting function according to the present invention includes pegmatite, silicon dioxide, dental type silica, allantoin chlorohydroxyaluminum, aminocaproic acid, D-sorbitol solution, concentrated glycerin, polyethylene glycol 1500, sodium carboxymethylcellulose, Matricaria extract, sage extract, eucalyptus extract, aloe extract, grapefruit seed extract, xylitol, enzyme-treated stevia, L-menthol, mint flavor, mica, silver foil, sodium cocoyl glutamate and purified water are included in a certain ratio.

상기 페그마타이트는 치태 제거, 구취 제거 및 항균성을 향상시킨다. 페그마타이트는 상온에서 원적외선을 다량 방출하고 탈취효과와 항균효과를 나타내는 천연석으로서, 페그마타이트(Pegmatite)의 분말을 치약 조성물에 함유시킴으로써, 구강내 독소와 염증제거 및 통증완화의 약리작용에 활용할 수 있으나, 지금까지 치약에 사용되고 있지 않는 실정이다.The pegmatite improves plaque removal, bad breath removal and antibacterial properties. Pegmatite is a natural stone that emits a large amount of far-infrared rays at room temperature and exhibits deodorizing and antibacterial effects. By containing pegmatite powder in the toothpaste composition, it can be used for the pharmacological action of removing toxins and inflammation in the oral cavity and relieving pain. Until now, it has not been used in toothpaste.

종래 공지된 연마제로는 탄산칼슘, 인산칼슘, 이산화규소, 인산칼슘, 무수규산, 수산화알루미늄 등이 있으나, 본 발명은 연마제로서 페그마타이트, 이산화규소, 덴탈타입실리카의 조합을 사용하는 것이 특징이다.Conventionally known abrasives include calcium carbonate, calcium phosphate, silicon dioxide, calcium phosphate, silicic anhydride, aluminum hydroxide, etc., but the present invention is characterized by using a combination of pegmatite, silicon dioxide, and dental type silica as an abrasive.

본 발명에서 연마제로 사용되는 페그마타이트, 이산화규소, 덴탈타입실리카는 치아에 부착된 치구, 치석 등을 제거하여 치아 표면에 본연의 광택을 주는 작용을 한다. 연마력은 연마제의 종류, 배합량, 연마제의 입자 크기에 따라 결정되고, 통상 20μm까지는 입자가 커짐에 따라 연마력도 함께 높아진다.Pegmatite, silicon dioxide, and dental type silica used as abrasives in the present invention act to give natural gloss to the tooth surface by removing jigs, tartar, etc. attached to the teeth. The abrasive power is determined according to the type of abrasive, the amount of the abrasive, and the particle size of the abrasive, and as the particle size increases up to 20 μm, the grinding power also increases.

또한, 연마제는 백색의 무미, 무취의 분말상으로서, 치아의 상태를 손상시키지 않을 정도의 경도를 유지해야 하고, 입자의 결정은 침상이나 봉상 등 치아의 손상을 유발하는 형상은 회피해야 하며, 입자의 지름은 1~20μm로 작아야 하고, pH는 약산성 중성 또는 약알칼리성인 것이 바람직하다.In addition, the abrasive is a white, tasteless, odorless powder, and must maintain hardness enough not to damage the state of the teeth. The diameter should be as small as 1-20 μm, and the pH is preferably slightly acidic, neutral or slightly alkaline.

한편, 상기 이산화규소는 바람직한 연마 효과를 갖기 위해 6~22μm의 크기인 것이 바람직하고, 상기 덴탈타입실리카는 자극 없이 치태의 침착을 예방시켜주고 치아를 건강하고 하얗게 하는 효과가 있다.On the other hand, the silicon dioxide preferably has a size of 6 to 22 μm in order to have a desirable polishing effect, and the dental type silica has the effect of preventing the deposition of plaque without irritation and making the teeth healthy and white.

또한, 본 발명의 조성물에서 아미노카프로산 및 알란토인클로로히드록시알루미늄은 치주질환 예방제로서 사용되되, 아미노카프로산은 항출혈 항염증 효능이 우수하여 지혈 작용을 통해 잇몸의 출혈을 예방하고, 알란토인클로로히드록시알루미늄은 구강점막을 보호하여 잇몸염증 방지, 치은염 및 치주염에 수반되는 부기 및 발적을 예방하며 잇몸 염증과 통증을 경감해 주는 효과가 있다.In addition, in the composition of the present invention, aminocaproic acid and allantoin chlorohydroxyaluminum are used as a preventive agent for periodontal disease, but aminocaproic acid has excellent anti-bleeding and anti-inflammatory effects to prevent bleeding of the gums through hemostasis, and allantoin chlorohydroxy Aluminum protects the oral mucosa to prevent gum inflammation, prevent swelling and redness accompanying gingivitis and periodontitis, and reduce gum inflammation and pain.

이하, 본 발명의 목적을 달성할 수 있는 구강내 세균억제 기능을 갖는 치약 조성물의 구체적인 조성물과 그에 따른 성분비를 설명하면 다음과 같다.Hereinafter, a specific composition of a toothpaste composition having an oral bacteriostatic function capable of achieving the object of the present invention and a component ratio thereof will be described as follows.

치약 조성물의 총중량에 대하여 페그마타이트 1.50~2.50중량%, 이산화규소 1.50~8.50중량%, 덴탈타입실리카 10.42~17.60중량%, 알란토인클로로히드록시알루미늄 0.04~0.06중량%, 아미노카프로산 0.02~0.06중량%, D-소르비톨액 26.00~70.00중량%, 농글리세린 4.00~6.00중량%, 폴리에틸렌글리콜1500 0.60~1.40중량%, 카르복시메틸셀룰로오스나트륨 0.60~1.40중량%, 마트리카리아엑스 0.06~0.14중량%, 세이지엑스 0.06~0.14중량%, 유칼립투스추출물 0.06~0.14중량%, 알로에엑스 0.06~0.14중량%, 자몽종자추출물 0.12~0.28중량%, 자일리톨 0.06~0.14중량%, 효소처리스테비아 0.04~0.06중량%, L-멘톨 0.30~0.60중량%, 민트향 0.10~0.30중량%, 마이카 0.20~0.60중량%, 은박 0.006~0.014중량%, 코코일글루타민산나트륨 1.00~3.00중량% 및 정제수 8.58~31.60중량%가 일정한 비율로 포함된다.Based on the total weight of the toothpaste composition, 1.50 to 2.50% by weight of pegmatite, 1.50 to 8.50% by weight of silicon dioxide, 10.42 to 17.60% by weight of dental type silica, 0.04 to 0.06% by weight of allantoin chlorohydroxyaluminum, 0.02 to 0.06% by weight of aminocaproic acid, D-sorbitol solution 26.00-70.00 wt%, concentrated glycerin 4.00-6.00 wt%, polyethylene glycol 1500 0.60-1.40 wt%, carboxymethyl cellulose sodium 0.60-1.40 wt%, Matricaria extract 0.06-0.14 wt%, Sage extract 0.06 ~0.14% by weight, eucalyptus extract 0.06 to 0.14% by weight, aloe extract 0.06 to 0.14% by weight, grapefruit seed extract 0.12 to 0.28% by weight, xylitol 0.06 to 0.14% by weight, enzyme-treated stevia 0.04 to 0.06% by weight, L-menthol 0.30 ~0.60% by weight, mint flavor 0.10 to 0.30% by weight, mica 0.20 to 0.60% by weight, silver foil 0.006 to 0.014% by weight, sodium cocoyl glutamate 1.00 to 3.00% by weight, and purified water 8.58 to 31.60% by weight are included in a constant ratio.

상기한 조성물들의 구체적인 성분비가 포함된 실시예는 다음과 같다.Examples including specific component ratios of the above compositions are as follows.

치약 조성물의 총중량 750.00g에 대하여 페그마타이트 1.50~2.50중량%에 해당하는 11.25~18.75g과, 이산화규소 1.50~8.50중량%에 해당하는 11.25~63.75g과, 덴탈타입실리카 10.42~17.60중량%에 해당하는 78.15~132.00g과, 알란토인클로로히드록시알루미늄 0.04~0.06중량%에 해당하는 0.30~0.45g과, 아미노카프로산 0.02~0.06중량%에 해당하는 0.15~0.45g과, D-소르비톨액 26.00~70.00중량%에 해당하는 195.00~525.00g과, 농글리세린 4.00~6.00중량%에 해당하는 30.00~45.00g과, 폴리에틸렌글리콜1500 0.60~1.40중량%에 해당하는 4.50~10.50g과, 카르복시메틸셀룰로오스나트륨 0.60~1.40중량%에 해당하는 4.50~10.50g과, 마트리카리아엑스 0.06~0.14중량%에 해당하는 0.45~1.05g과, 세이지엑스 0.06~0.14중량%에 해당하는 0.45~1.05g과, 유칼립투스추출물 0.06~0.14중량%에 해당하는 0.45~1.05g과, 알로에엑스 0.06~0.14중량%에 해당하는 0.45~1.05g과, 자몽종자추출물 0.12~0.28중량%에 해당하는 0.90~2.10g과, 자일리톨 0.06~0.14중량%에 해당하는 0.45~1.05g과, 효소처리스테비아 0.04~0.06중량%에 해당하는 0.30~0.45g과, L-멘톨 0.30~0.60중량%에 해당하는 2.25~4.50g과, 민트향 0.10~0.30중량%에 해당하는 0.75~2.25g과, 마이카 0.20~0.60중량%에 해당하는 1.50~4.50g과, 은박 0.006~0.014중량%에 해당하는 0.05~0.11g과, 코코일글루타민산나트륨 1.00~3.00중량%에 해당하는 7.50~22.50g과 및 정제수 8.58~31.60중량%에 해당하는 64.35~237.00g을 포함시켜 진공상태에서 20분간 교반시키면서 점성이 있는 페이스트 상태로 본 발명의 구강내 세균억제 기능을 갖는 치약 조성물이 제조된다.With respect to the total weight of the toothpaste composition 750.00g, 11.25-18.75g corresponding to 1.50 to 2.50% by weight of pegmatite, 11.25 to 63.75g corresponding to 1.50 to 8.50% by weight of silicon dioxide, and 10.42 to 17.60% by weight of dental type silica 78.15~132.00g, 0.30~0.45g corresponding to 0.04~0.06% by weight of allantoin chlorohydroxyaluminum, 0.15~0.45g corresponding to 0.02~0.06% by weight of aminocaproic acid, and 26.00~70.00 weight of D-sorbitol solution 195.00~525.00g corresponding to %, 30.00~45.00g corresponding to 4.00~6.00% by weight of concentrated glycerin, 4.50~10.50g corresponding to 0.60~1.40% by weight of polyethylene glycol 1500, and 0.60~1.40% by weight of sodium carboxymethylcellulose 4.50~10.50g corresponding to weight %, 0.45~1.05g corresponding to 0.06~0.14% by weight of Matricaria extract, 0.45~1.05g corresponding to 0.06~0.14% by weight of sage extract, 0.06~0.14 eucalyptus extract 0.45 to 1.05 g corresponding to weight percent, 0.45 to 1.05 g corresponding to 0.06 to 0.14 weight percent of aloe extract, 0.90 to 2.10 g corresponding to 0.12 to 0.28 weight percent of grapefruit seed extract, and 0.06 to 0.14 weight percent of xylitol 0.45~1.05g corresponding to , 0.30~0.45g corresponding to 0.04~0.06% by weight of enzyme-treated stevia, 2.25~4.50g corresponding to 0.30~0.60% by weight of L-menthol, and 0.10~0.30% by weight of mint flavor Corresponding to 0.75 to 2.25 g corresponding to mica, 1.50 to 4.50 g corresponding to 0.20 to 0.60 wt% of mica, 0.05 to 0.11 g corresponding to 0.006 to 0.014 wt% of silver foil, and 1.00 to 3.00 wt% of sodium cocoylglutamate 7.50 to 22.50 g and 64.35 to 237.00 g corresponding to 8.58 to 31.60% by weight of purified water, and stirred in a vacuum for 20 minutes, in the form of a viscous paste, a toothpaste composition having an oral bacterial inhibiting function of the present invention do .

참고로, 상기와 같은 각각의 조성물에서 각각의 성분중 최저치의 수치로만 본 발명에 따른 구강내 세균억제 기능을 갖는 치약 조성물을 만들면 치약 조성물의 총중량은 414.95g이 되고, 각각의 성분중 최고치의 수치로만 본 발명에 따른 치약 조성물을 만들면 치약 조성물의 총중량은 1,085.06g이 됨에 따라, 상기한 실시예처럼 본 발명에 따른 치약 조성물은 414.95~1,085.06g 사이에서 만들어지는 것이 바람직하다.For reference, if a toothpaste composition having an oral bacteriostatic function according to the present invention is made only with the lowest value among each component in each composition as described above, the total weight of the toothpaste composition is 414.95 g, and the highest value among each component When the toothpaste composition according to the present invention is made, the total weight of the toothpaste composition is 1,085.06 g. As in the above embodiment, the toothpaste composition according to the present invention is preferably made between 414.95 to 1,085.06 g.

이러한 실시예는 하나의 예시일 뿐, 본 발명은 이에 한정되지 않으며, 치약 조성물의 총중량을 늘리면서 대량으로 생산할 때에는 각각의 성분비의 범위내에서 얼마든지 대량으로 치약 조성물을 만들 수 있다.These examples are only an example, and the present invention is not limited thereto, and when mass-produced while increasing the total weight of the toothpaste composition, the toothpaste composition can be prepared in large quantities within the range of each component ratio.

Claims (1)

치약 조성물의 총중량에 대하여 페그마타이트 1.50~2.50중량%, 이산화규소 1.50~8.50중량%, 덴탈타입실리카 10.42~17.60중량%, 알란토인클로로히드록시알루미늄 0.04~0.06중량%, 아미노카프로산 0.02~0.06중량%, D-소르비톨액 26.00~70.00중량%, 농글리세린 4.00~6.00중량%, 폴리에틸렌글리콜1500 0.60~1.40중량%, 카르복시메틸셀룰로오스나트륨 0.60~1.40중량%, 마트리카리아엑스 0.06~0.14중량%, 세이지엑스 0.06~0.14중량%, 유칼립투스추출물 0.06~0.14중량%, 알로에엑스 0.06~0.14중량%, 자몽종자추출물 0.12~0.28중량%, 자일리톨 0.06~0.14중량%, 효소처리스테비아 0.04~0.06중량%, L-멘톨 0.30~0.60중량%, 민트향 0.10~0.30중량%, 마이카 0.20~0.60중량%, 은박 0.006~0.014중량%, 코코일글루타민산나트륨 1.00~3.00중량% 및 정제수 8.58~31.60중량%가 포함되고, 상기 이산화규소의 입자 크기는 6~22μm이며, 상기 덴탈타입실리카 및 페그마타이트의 입자 크기는 각각 1~20μm인 것을 특징으로 하는 구강내 세균억제 기능을 갖는 치약 조성물.Based on the total weight of the toothpaste composition, 1.50 to 2.50% by weight of pegmatite, 1.50 to 8.50% by weight of silicon dioxide, 10.42 to 17.60% by weight of dental type silica, 0.04 to 0.06% by weight of allantoin chlorohydroxyaluminum, 0.02 to 0.06% by weight of aminocaproic acid, D-sorbitol solution 26.00-70.00 wt%, concentrated glycerin 4.00-6.00 wt%, polyethylene glycol 1500 0.60-1.40 wt%, carboxymethyl cellulose sodium 0.60-1.40 wt%, Matricaria extract 0.06-0.14 wt%, Sage extract 0.06 ~0.14% by weight, eucalyptus extract 0.06 to 0.14% by weight, aloe extract 0.06 to 0.14% by weight, grapefruit seed extract 0.12 to 0.28% by weight, xylitol 0.06 to 0.14% by weight, enzyme-treated stevia 0.04 to 0.06% by weight, L-menthol 0.30 ~0.60% by weight, mint flavor 0.10 ~ 0.30% by weight, mica 0.20 ~ 0.60% by weight, silver foil 0.006 ~ 0.014% by weight, sodium cocoyl glutamate 1.00 ~ 3.00% by weight and purified water 8.58 ~ 31.60% by weight contained, the silicon dioxide has a particle size of 6 to 22 μm, and the dental type silica and pegmatite have a particle size of 1 to 20 μm, respectively. A toothpaste composition having an oral bacterial inhibitory function.
KR1020190159425A 2019-12-03 2019-12-03 The toothpaste composition having oral bactericidal function KR20210069513A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190159425A KR20210069513A (en) 2019-12-03 2019-12-03 The toothpaste composition having oral bactericidal function

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190159425A KR20210069513A (en) 2019-12-03 2019-12-03 The toothpaste composition having oral bactericidal function

Publications (1)

Publication Number Publication Date
KR20210069513A true KR20210069513A (en) 2021-06-11

Family

ID=76376533

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190159425A KR20210069513A (en) 2019-12-03 2019-12-03 The toothpaste composition having oral bactericidal function

Country Status (1)

Country Link
KR (1) KR20210069513A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117323241A (en) * 2023-10-24 2024-01-02 金三江(肇庆)硅材料股份有限公司 Silica particles for oral cavity as well as preparation method and application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117323241A (en) * 2023-10-24 2024-01-02 金三江(肇庆)硅材料股份有限公司 Silica particles for oral cavity as well as preparation method and application thereof
CN117323241B (en) * 2023-10-24 2024-05-28 金三江(肇庆)硅材料股份有限公司 Silica particles for oral cavity as well as preparation method and application thereof

Similar Documents

Publication Publication Date Title
RU2166932C2 (en) Combined preparation for teeth whitening or treatment of skin and mucosa disease, method of preparing and set
US3651208A (en) Dentifrice for periodontia purposes
JP2005504109A5 (en)
WO1992007550A1 (en) Plaque adsorbent oral composition and method
KR101992927B1 (en) Toothpaste composition for prevention and improvement of periodontal disease
JPH0776510A (en) Oral hygiene promoting composition containing bamboo salt
AU2009212339B2 (en) Tooth sealant
JP2014144989A (en) Dentifrice composition, oral antiinflammatory agent and halitosis improvement agent
JPH1017449A (en) Composition for hyperesthesia
KR20190130786A (en) The toothpaste composition
KR20210069513A (en) The toothpaste composition having oral bactericidal function
KR101216427B1 (en) Calendula officinalis dentifrice composition and process for preparing the same
JP2021095380A (en) Dentifrice composition
JP2016124855A (en) Oral hydrogel composition
KR20110129046A (en) Functional toothpaste component
JP2009155216A (en) Composition for oral cavity
KR20190087701A (en) Anti-ache toothpaste containing extracts from hemp seed and yam
JP7337610B2 (en) oral composition
JP3615860B2 (en) Oral composition
KR102196459B1 (en) A toothpaste composition with improved antibacterial performance and a toothpaste comprising the composition
US10894004B2 (en) Composition
KR101583758B1 (en) Toothpaste composition comprising kiyoseki stone
Stoleriu et al. The use of arginine containing toothpastes in dental hard tissues remineralization
RU2240776C1 (en) Dental paste "parodontol" with triple effect
US20060093563A1 (en) Oral antimicrobial composition and use thereof in treating of dental plaque and gingivitis